Cargando…
Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine
The non-benzodiazepine hypnotic zolpidem is frequently administered as a short term psychopharmacotherapy for insomnia. Although it is well-established in a broad clinical routine and often well-tolerated, severe delirium and complex sleep behavior were reported in rare cases. Hereby, it remains unc...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413097/ https://www.ncbi.nlm.nih.gov/pubmed/37575586 http://dx.doi.org/10.3389/fpsyt.2023.1204009 |
_version_ | 1785087061477294080 |
---|---|
author | Preiss, Maximilian Rabl, Ulrich Popper, Valentin Watzal, Victoria Treiber, Michael Ivkic, Dominik Praschak-Rieder, Nicole Naderi-Heiden, Angela Fugger, Gernot Frey, Richard Rujescu, Dan Bartova, Lucie |
author_facet | Preiss, Maximilian Rabl, Ulrich Popper, Valentin Watzal, Victoria Treiber, Michael Ivkic, Dominik Praschak-Rieder, Nicole Naderi-Heiden, Angela Fugger, Gernot Frey, Richard Rujescu, Dan Bartova, Lucie |
author_sort | Preiss, Maximilian |
collection | PubMed |
description | The non-benzodiazepine hypnotic zolpidem is frequently administered as a short term psychopharmacotherapy for insomnia. Although it is well-established in a broad clinical routine and often well-tolerated, severe delirium and complex sleep behavior were reported in rare cases. Hereby, it remains unclear whether zolpidem's potential for delirium might be enhanced when combined with further psychopharmacotherapeutics. The present case report portrays a young male Caucasian inpatient with schizoaffective disorder, who was admitted due to severe hyperactive delirium after a single dose of zolpidem 10 mg that was administered in addition to already established psychopharmacotherapy including clozapine 200 mg/day, aripiprazole 15 mg/day and cariprazine 4.5 mg/day. In detail, disorientation, agitation, confabulations, bizarre behavior, and anterograde amnesia occurred shortly after ingestion of zolpidem and gained in intensity within a couple of hours. Once zolpidem was discontinued, the abovementioned symptoms subsided completely and did not reoccur. Since a clear temporal association could be drawn between the intake of zolpidem and the onset of hyperactive delirium, the present clinical experience should serve as a cautionary note for combining potent sedative-hypnotics and substances with anticholinergic properties, even in young adults in a good general condition. Moreover, our case argues for the necessity of further research into the pathomechanism of the interaction potential of non-benzodiazepines as zolpidem, especially with substances exerting anticholinergic properties, which are known for their potential to precipitate delirium. Therefore, the metabolic pathways of the concurrently administered substances should be further taken into account. |
format | Online Article Text |
id | pubmed-10413097 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104130972023-08-11 Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine Preiss, Maximilian Rabl, Ulrich Popper, Valentin Watzal, Victoria Treiber, Michael Ivkic, Dominik Praschak-Rieder, Nicole Naderi-Heiden, Angela Fugger, Gernot Frey, Richard Rujescu, Dan Bartova, Lucie Front Psychiatry Psychiatry The non-benzodiazepine hypnotic zolpidem is frequently administered as a short term psychopharmacotherapy for insomnia. Although it is well-established in a broad clinical routine and often well-tolerated, severe delirium and complex sleep behavior were reported in rare cases. Hereby, it remains unclear whether zolpidem's potential for delirium might be enhanced when combined with further psychopharmacotherapeutics. The present case report portrays a young male Caucasian inpatient with schizoaffective disorder, who was admitted due to severe hyperactive delirium after a single dose of zolpidem 10 mg that was administered in addition to already established psychopharmacotherapy including clozapine 200 mg/day, aripiprazole 15 mg/day and cariprazine 4.5 mg/day. In detail, disorientation, agitation, confabulations, bizarre behavior, and anterograde amnesia occurred shortly after ingestion of zolpidem and gained in intensity within a couple of hours. Once zolpidem was discontinued, the abovementioned symptoms subsided completely and did not reoccur. Since a clear temporal association could be drawn between the intake of zolpidem and the onset of hyperactive delirium, the present clinical experience should serve as a cautionary note for combining potent sedative-hypnotics and substances with anticholinergic properties, even in young adults in a good general condition. Moreover, our case argues for the necessity of further research into the pathomechanism of the interaction potential of non-benzodiazepines as zolpidem, especially with substances exerting anticholinergic properties, which are known for their potential to precipitate delirium. Therefore, the metabolic pathways of the concurrently administered substances should be further taken into account. Frontiers Media S.A. 2023-07-27 /pmc/articles/PMC10413097/ /pubmed/37575586 http://dx.doi.org/10.3389/fpsyt.2023.1204009 Text en Copyright © 2023 Preiss, Rabl, Popper, Watzal, Treiber, Ivkic, Praschak-Rieder, Naderi-Heiden, Fugger, Frey, Rujescu and Bartova. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Preiss, Maximilian Rabl, Ulrich Popper, Valentin Watzal, Victoria Treiber, Michael Ivkic, Dominik Praschak-Rieder, Nicole Naderi-Heiden, Angela Fugger, Gernot Frey, Richard Rujescu, Dan Bartova, Lucie Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine |
title | Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine |
title_full | Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine |
title_fullStr | Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine |
title_full_unstemmed | Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine |
title_short | Case report: Hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine |
title_sort | case report: hyperactive delirium after a single dose of zolpidem administered additionally to psychopharmacotherapy including clozapine |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413097/ https://www.ncbi.nlm.nih.gov/pubmed/37575586 http://dx.doi.org/10.3389/fpsyt.2023.1204009 |
work_keys_str_mv | AT preissmaximilian casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT rablulrich casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT poppervalentin casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT watzalvictoria casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT treibermichael casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT ivkicdominik casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT praschakriedernicole casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT naderiheidenangela casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT fuggergernot casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT freyrichard casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT rujescudan casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine AT bartovalucie casereporthyperactivedeliriumafterasingledoseofzolpidemadministeredadditionallytopsychopharmacotherapyincludingclozapine |